Evidence map›Paper›PMID 42894649›Full record

ArticlePhysics and imaging in radiation oncology2026

Integration of an echocardiographic motion-management system into photon-based stereotactic arrhythmia radioablation planning.

Hans Oppitz, Amelie L Matusche, Laura Mantovani, Mathieu Kruska, Kerstin Siebenlist, Nour Alfakhouri, Adriano Garonna, Elisabetta Bonzano, Ester Orlandi, Viviana Vitolo and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Hans OppitzDepartment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Amelie L MatuscheDepartment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Laura MantovaniDepartment of Medical Physics, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Policlinico San Matteo, Viale Camillo Golgi 19, 27100 Pavia, Italy.
Mathieu KruskaDepartment of Cardiology, Haemostaseology and Medical Intensive Care, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, European Center for AngioScience (ECAS), and German Center for Cardiovascular Research (DZHK) Partner Site Heidelberg/Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Kerstin SiebenlistDepartment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Nour AlfakhouriDepartment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Adriano GaronnaEBAMed SA, Chemin des Mines 15, CH-1202 Geneva, Switzerland.
Elisabetta BonzanoDepartment of Radiation Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Policlinico San Matteo, Viale Camillo Golgi 19, 27100 Pavia, Italy.
Ester OrlandiDepartment of Radiation Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Policlinico San Matteo, Viale Camillo Golgi 19, 27100 Pavia, Italy.
Viviana VitoloRadiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, Via Erminio Borloni, 1, 27100 Pavia, Italy.
Adele ValentiniDepartment of Diagnostic Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Policlinico San Matteo, Viale Camillo Golgi 19, 27100 Pavia, Italy.
Nicoletta BaslaDepartment of Diagnostic Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Policlinico San Matteo, Viale Camillo Golgi 19, 27100 Pavia, Italy.
Frank A GiordanoDepartment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Oliver BlanckDepartment of Radiation Oncology, University Medical Center Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Roberto RordorfArrhythmias and Electrophysiology Unit, Division of Cardiology, Fondazione Policlinico San Matteo, Viale Camillo Golgi 19, 27100 Pavia, Italy.
Jens FleckensteinDepartment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Judit Boda-HeggemannDepartment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
Lena KästnerDepartment of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Cardiorespiratory ultrasound motion monitoring may enhance the precision of dose delivery for stereotactic arrhythmia radioablation (STAR) of ventricular tachycardia. This treatment planning study aimed to evaluate the feasibility of photon-based STAR planning in the presence of an ultrasound probe. Materials and methods: For sixteen targets in fourteen patients, three treatment plans were retrospectively created and compared: a reference plan without an ultrasound probe and two plans in which the ultrasound probe was spared from the primary treatment beam (apical or parasternal probe positions). Descriptive and statistical analyses were performed for target/organ dose-volume and treatment beam metrics, conformity-indices and maximum probe exposure. Results: The ultrasound probe could be spared from the primary beam in all cases with D Conclusions: The ultrasound probe could be spared from the primary beam without compromising photon-based STAR plan quality beyond clinically acceptable deviations. The results support further investigation of ultrasound-based STAR motion management.

Indexed as

FeasibilityPlanning implementationSTAR (Stereotactic arrhythmia radioablation)Ultrasound-based cardiorespiratory tracking/ gating

Identifiers

PMID42894649
PMCPMC13676723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.